13.07.2015 Views

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Medical</strong> <strong>Aspects</strong> <strong>of</strong> <strong>Chemical</strong> <strong>Warfare</strong>pediatric nerve agent antidote dosing schedule, 684City <strong>of</strong> New York Fire Departmentpediatric nerve agent antidote dosing schedule, 684Civil War. See US Civil WarCK. See Cyanogen chlorideClark, M.G.plasma-derived human butyrylcholinesterase research, 249Clean Air Actdestruction <strong>of</strong> chemical weapons stockpile and, 610Clermonttetraethyl pyrophosphate testing, 46, 156Clinton, Pres. Billpresidential decision directives outlining policy for deterringand responding to terrorism, 754Clonidineincapacitating effects, 421Cluster bombschemical weapon delivery, 120, 122CN. See chloroacetophenone; 1-chloroacetophenoneCobalt EDTAcyanide poisoning treatment, 385, 397Cobalt saltscyanide poisoning treatment, 397Cochrane, Capt. Charlesbatrachotoxin description, 632–633Cochrane, RexmondBattle <strong>of</strong> Cantigny and, 27Cohn Fraction IV-4 pasteplasma-derived human butyrylcholinesterase source, 247, 249,251Cole, T.J.2-chlorobenzylidene malononitrile research, 450Colgrave, H.F.dibenz[b,f]-1,4-oxazepine research, 467, 469Collective protectioncategories <strong>of</strong>, 584chemical and biological protected shelters, 585–586chemically protected deployable medical system, 584–585collectively protected expeditionary medical support, 585M20 simplified collective protection equipment, 586–587modular general purpose tent system chemical-biologicalprotective liner system, 587tactical application, 584Collectively protected expeditionary medical supportdescription, 585Colombian poison dart frogsbatrachotoxin source, 632COLPRO. See Collective protectionComboPen2-pyridine aldoxime methyl chloride administration, 187Cone, D.C.summary <strong>of</strong> triage systems, 517Conner, M.W.hexachloroethane smoke research, 327Convulsive Antidote, Nerve Agent injectordiazepam administration, 189–190nerve agent exposure treatment, 651Cooper, G.J.wound decontamination research, 538–539Cooper, W.C.organophosphate insecticide exposure research, 320Corson, B.B.2-chlorobenzylidene malononitrile research, 444Corticosteroids. See also specific agentsammonia inhalation treatment, 353brevetoxin intoxication treatment, 631chlorine exposure treatment, 673incapacitating agent exposure treatment, 471mustard agent exposure treatment, 282phosgene inhalation treatment, 354, 363toxic industrial chemical exposure treatment, 363<strong>The</strong> Covenant, the Sword, and the Arm <strong>of</strong> the Lordchemical attack plan, 127CP EMEDS. See Collectively protected expeditionary medicalsupportCR. See Dibenz[b,f]-1,4-oxazepineCreasy, Maj. Gen. Williamlysergic acid diethylamide research, 414Crone, H.D.decontamination research, 529CS. See O-chlorobenzylidene malononitrile; 2-chlorobenzylidenemalonitrileCSA. See <strong>The</strong> Covenant, the Sword, and the Arm <strong>of</strong> the LordCSEPP. See <strong>Chemical</strong> Stockpile Emergency Preparedness ProgramCurran, D.anticholinergic deliriant research, 422Currie, W.D.phosgene research, 738Cushing, Dr. Harveyaccount <strong>of</strong> Royal Army <strong>Medical</strong> Corps capabilities, Flanders,Belgium, May 5, 1917 (exhibit), 88chemical attack observations, 101initial impressions <strong>of</strong> mustard agent, 88–89observations <strong>of</strong> the Second Battle <strong>of</strong> Ypres, 82CVAA. See Chlorovinylarsonous acidCWC. See <strong>Chemical</strong> Weapons ConventionCWS. See <strong>Chemical</strong> <strong>Warfare</strong> ServiceCyanide. See also Cyanogen chloride; Hydrogen cyanideaccidental exposures, 374advantages and disadvantages <strong>of</strong>, 3, 126analytical methods for determining cyanide in biologicalsamples (table), 732–733chemical, physical, environmental, and biological properties(table), 372conventional wounds contaminated with, 523description, 322, 731dietary issues, 323, 372–373, 374, 389endogenous cyanide concentrations for smokers and nonsmokers(table), 381executions and suicides and, 373–374“gas chambers” and, 373–374Germany’s experimental testing on human subjects in concentrationcamps, 105goiter and, 324historical use, 372–373long-term exposure to, 323–324long-term health effects, 322–324mechanism <strong>of</strong> action, 343, 397, 731mechanism <strong>of</strong> toxicity, 673–674, 731military use, 372, 373pharmacokinetics and pharmacodynamics, 376physiology, 322quick-kill properties, 373reference range values, 734routes <strong>of</strong> exposure, 322sources, 372, 374, 731terrorist plots using, 4tobacco smoke and, 323, 324, 374toxicity, 377toxicodynamic effects (figure), 384Tylenol poisoned with, 373uses for, 673volatility <strong>of</strong>, 373World War I use, 372, 373xxxiv

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!